Valeo Financial Advisors, LLC Corcept Therapeutics Inc Transaction History

Valeo Financial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$19.97 - $24.43 $35,526 - $43,460	-1,779 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$23.49 - $30.56 $23,490 - $30,560	-1,000 Reduced 35.98%	1,779 $42,000
Q4 2020 Feb 11, 2021	SELL	$16.78 - $27.3 $83,900 - $136,500	-5,000 Reduced 64.28%	2,779 $73,000
Q3 2020 Oct 28, 2020	SELL	$12.46 - $19.98 $60,580 - $97,142	-4,862 Reduced 38.46%	7,779 $135,000
Q2 2020 Jul 20, 2020	SELL	$11.0 - $18.26 $54,010 - $89,656	-4,910 Reduced 27.98%	12,641 $213,000
Q1 2020 Apr 13, 2020	SELL	$10.11 - $14.04 $6,207 - $8,620	-614 Reduced 3.38%	17,551 $213,000
Q4 2019 Jan 24, 2020	BUY	$12.06 - $16.96 $361 - $508	30 Added 0.17%	18,165 $220,000
Q3 2019 Oct 15, 2019	SELL	$10.41 - $14.66 $2,321 - $3,269	-223 Reduced 1.21%	18,135 $256,000
Q2 2019 Jul 10, 2019	SELL	$9.78 - $12.76 $4,283 - $5,588	-438 Reduced 2.33%	18,358 $205,000
Q1 2019 Apr 12, 2019	BUY	$10.03 - $15.71 $188,523 - $295,285	18,796 New	18,796 $221,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.